Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Breast Cancer
Interventions
OTHER

Questionnaire

A questionnaire will be given to patients who will ask them about their possible fractures, their bone and oncological follow-ups and their possible cardiovascular events since the end of treatment with hormone therapy.

Trial Locations (1)

Unknown

CHU Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT05049031 - Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk | Biotech Hunter | Biotech Hunter